Anti-EphA4 (N-terminal region) Antibody (M280)

3 Citations

Our EphA4 (N-terminal region) mouse monoclonal primary antibody from PhosphoSolutions is produced in-house. It detects chicken, human, mouse, and rat EphA4 (N-terminal region) and is Protein A purified. It is great for use in WB.

Western blot analysis of human umbilical vein endothelial cells untreated (lanes 1, 3, 5, & 7) or treated with pervanadate (1 mM) for 30 min. (lanes 2, 4, 6, & 8). The blot was probed with anti-EphA4 (N-terminal region) (lanes 1 & 2), anti-EphA4 (Tyr-779) (lanes 3 & 4), anti-EphA4 (Tyr-602) (lanes 5 & 6), or anti-EphA4 (C-terminal region) (lanes 7 & 8).
Western blot image of various mouse and human HCC cell lines expressing EphA4 (Cat no EM2801, 1:1000). Image from publication CC-BY-4.0. PMID: 38307859
Western blot image of mouse HCA-1 (left) and human Hep3B (right) cells treated with RNase1 (1 ug/ml) at the indicated time points specifically labeling EphA4 (EM2801, 1:1000) and phosphorylated EphA4-Tyr604 (EP2731, 1:1000) Image from publication CC-BY-4.0. PMID: 38307859
Western blot analysis of human umbilical vein endothelial cells untreated (lanes 1, 3, 5, & 7) or treated with pervanadate (1 mM) for 30 min. (lanes 2, 4, 6, & 8). The blot was probed with anti-EphA4 (N-terminal region) (lanes 1 & 2), anti-EphA4 (Tyr-779) (lanes 3 & 4), anti-EphA4 (Tyr-602) (lanes 5 & 6), or anti-EphA4 (C-terminal region) (lanes 7 & 8).
Roll over image to zoom in Click on image to zoom
Western blot analysis of human umbilical vein endothelial cells untreated (lanes 1, 3, 5, & 7) or treated with pervanadate (1 mM) for 30 min. (lanes 2, 4, 6, & 8). The blot was probed with anti-EphA4 (N-terminal region) (lanes 1 & 2), anti-EphA4 (Tyr-779) (lanes 3 & 4), anti-EphA4 (Tyr-602) (lanes 5 & 6), or anti-EphA4 (C-terminal region) (lanes 7 & 8).
Western blot image of various mouse and human HCC cell lines expressing EphA4 (Cat no EM2801, 1:1000). Image from publication CC-BY-4.0. PMID: 38307859
Western blot image of mouse HCA-1 (left) and human Hep3B (right) cells treated with RNase1 (1 ug/ml) at the indicated time points specifically labeling EphA4 (EM2801, 1:1000) and phosphorylated EphA4-Tyr604 (EP2731, 1:1000) Image from publication CC-BY-4.0. PMID: 38307859

Chicken, Human, Mouse, Rat
WB
Mouse

Go to Full Product Details

Data Sheet

SKU: EM2801

Volume: 100 µL
Price:
$340.00
Ships: 1-2 business days

Product Specific References for Applications and Species

Western Blot: Human
PMID Dilution Publication
383078591:1000Liu, C, et al. 2024. Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature communications, 1009.
Western Blot: mouse
PMID Dilution Publication
383078591:1000Liu, C, et al. 2024. Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma. Nature communications, 1009.
297894181:1000Yang, WH, et al. 2018. Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 Expression. Cancer research, 3761-3768.
285267451:1000Schoonaert, L, et al. 2017. Identification and characterization of Nanobodies targeting the EphA4 receptor. The Journal of biological chemistry, 11452-11465.

Bulk Order Anti-EphA4 (N-terminal region) Antibody

Related Products

Recently Viewed